This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Today's Health Winners and Losers

Shares of Bausch & Lomb (BOL) were among the worst-performing health-related stocks Tuesday, slumping 17% after the eye-care company halted U.S. shipments of its ReNu with MoistureLoc contact-lens solution because of reports of fungal infections in contact lens wearers.

The suspension follows the release of a report by the U.S. Centers for Disease Control and Prevention that it is reviewing some 109 cases of suspected fungal keratitis, a rare infection that can cause vision loss. "The CDC data released today are both troubling and perplexing, as there is an apparent disproportionate representation of U.S. manufactured ReNu with MoistureLoc in the underlying data," Bausch & Lomb said.

Still, the company said that based on extensive testing, analysis and further internal reviews, "the available scientific evidence does not establish any type of ReNu solution as the cause."

The CDC has so far only reviewed 30 of the 109 cases, but 28 involved contact-lens wearers, Bausch & Lomb said. Of those 28 cases, 21 reported using ReNu contact-lens care products, while another five reported using a combination of ReNu and products made by other companies. Shares were trading down $9.85 to $47.59.

Alcon (ACL), a rival that could benefit from Bausch & Lomb's troubles, saw its shares rise $3 to $104.22, while shares of another competitor, Advanced Medical Optics (EYE), jumped $1.95 to $47.42.

Immucor (BLUD) rose 4% after the company announced a 3-for-2 stock split. The company, which sells reagents and systems used to identify the properties of blood, expects to distribute the shares May 15 to shareholders of record on April 24.

"We have experienced a consistent rise in the value of our stock as a result of the success of the Galileo and our continuing success in improving both gross and operating margins," the company said. "This stock split is a result of the success of these strategies." The stock split marks the eighth one for the company since going public in 1985.

Immucor shares, which have climbed about 35% since the last stock split in 2004, recently were up $1.10 to $31.09.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
GIVN $0.00 0.00%
BSX $21.92 0.00%
PRSC $49.84 0.00%
AAPL $93.74 0.00%
FB $117.58 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs